EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy—Reply

Kim A Boggess, MOMPOD Study PIs

JAMA · 2024

DOI: 10.1001/jama.2024.1383 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Kim A Boggess und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes, Gestational, Hypoglycemic Agents, Insulin. Die Arbeit nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetes, GestationalHypoglycemic AgentsInsulinMetforminPrenatal Exposure Delayed EffectsAdultChildFemaleHumansMalePregnancyDrug Therapy, CombinationSperm MotilitySpermatogenesis

Substanzen

Hypoglycemic AgentsInsulinMetformin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill.

Zitieren

APA

Boggess, K. A., & MOMPOD Study PIs (2024). Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy—Reply. JAMA. https://doi.org/10.1001/jama.2024.1383

Vancouver

Boggess KA, MOMPOD Study PIs. Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy—Reply. JAMA. 2024. doi:10.1001/jama.2024.1383

BibTeX
@article{Boggess2024,
  author = {Boggess, Kim A and MOMPOD Study PIs, MOMPOD Study PIs},
  title = {Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy—Reply},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.1383}
}
Kostenlos starten →